Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : URMD -- Huge market potential -- Ignore unavailable to you. Want to Upgrade?

To: rrufff who wrote (288)	6/18/1998 1:50:00 PM
From: Craig McNeill	Read Replies (2) \| Respond to of 369

They have $40-50m in cash according to their last press release. So they have the cash to do buy back. I understand their optimistic statements, but don't buy into them. They've got a $25m market cap but only $60,000 in sales last qtr. It has to be a logarithimic growth to justify that. And the fact that in yesterday's release their talking about being de-listed is just another bit of bad news. I'm going to take my 50% loss and run while the company is still propping up the price....their cash will run out, they will accumulate the 20% share, they will still be promising marketing alliances, they will be de-listed (bumped to bb probably) and their revenues might double to $120,000. I had anticipated much more and am deeply disappointed in my DD and the company's execution. Sorry, I'll get off my soapbox and look for shares again at $2-3. cm